SCHEMBL30967286

SCHEMBL30967286

CC(C)(C)c1ccc(C(COP(O)O)c2ccc(C(C)(C)C)cc2C(C)(C)C)c(C(C)(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
DNMT1 P26358 3/20 0.32
TRPV1 Q8NER1 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
RECQL P46063 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP2D6 P10635 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9487411 0.88 CYP2C19 (0.36) CYP2C19CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL1099782 0.87 CYP1A2 (0.34) CYP2C19CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL9174345 0.85 CYP1A2 (0.32) CYP2C19CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL2873118 0.81 CYP2C9 (0.33) CYP2C19CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL9175203 0.80 CYP1A2 (0.35) CYP2C19CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL1101082 0.78 CYP1A2 (0.33) CYP2C19CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL5470021 0.77 ALOX15 (0.47) CYP2C19CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL9278616 0.76 ALDH1A1 (0.36) CYP2C19CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL30967276 0.76 ALDH1A1 (0.36) CYP2C19CYP1A2CYP3A4CYP2C9TSHR
SCHEMBL7943128 0.76 ALDH1A1 (0.45) CYP2C19CYP1A2CYP3A4CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026089812-A1 POLYMER PROCESSING AIDS ExxonMobil Technology and Engineering Company (US) 2026-04-30 WO disclosed
US-20260117053-A1 POLYMER PROCESSING AIDS EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2026-04-30 US disclosed
CN-113710718-B Stabilized silane-modified polymer compositions and methods 迈图高新材料公司 2024-06-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260117053-A1 POLYMER PROCESSING AIDS PUF60, PFAS, PRPF40A CYP2C19 3064/4885CYP1A2 1662/4885CYP3A4 3166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.